Deutsche Bank’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.4M | Sell |
162,533
-92,654
| -36% | -$10.1M | 0.01% | 804 |
|
|
2026
Q1 | $23.6M | Sell |
255,187
-81,241
| -24% | -$8.16M | 0.01% | 804 |
|
|
2025
Q4 | $34.4M | Buy |
336,428
+576
| +0.2% | +$51.5K | 0.01% | 741 |
|
|
2025
Q3 | $21M | Buy |
335,852
+17,733
| +6% | +$965K | 0.01% | 842 |
|
|
2025
Q2 | $16.6M | Sell |
318,119
-428,517
| -57% | -$19.1M | 0.01% | 885 |
|
|
2025
Q1 | $31.8M | Sell |
746,636
-30,534
| -4% | -$1.32M | 0.01% | 721 |
|
|
2024
Q4 | $23.7M | Sell |
777,170
-526,557
| -40% | -$14.8M | 0.01% | 803 |
|
|
2024
Q3 | $29.9M | Buy |
1,303,727
+230,650
| +21% | +$6.53M | 0.01% | 743 |
|
|
2024
Q2 | $31M | Buy |
1,073,077
+58,065
| +6% | +$1.35M | 0.01% | 693 |
|
|
2024
Q1 | $20.9M | Sell |
1,015,012
-144,834
| -12% | -$3.1M | 0.01% | 801 |
|
|
2023
Q4 | $31.4M | Buy |
1,159,846
+1,076,584
| +1,293% | +$28.2M | 0.02% | 661 |
|
|
2023
Q3 | $2.47M | Sell |
83,262
-375,504
| -82% | -$13.2M | ﹤0.01% | 1280 |
|
|
2023
Q2 | $16.4M | Buy |
458,766
+406,029
| +770% | +$11.7M | 0.01% | 845 |
|
|
2023
Q1 | $1.24M | Sell |
52,737
-32,573
| -38% | -$930K | ﹤0.01% | 1971 |
|
|
2022
Q4 | $2.32M | Sell |
85,310
-66,199
| -44% | -$3.03M | ﹤0.01% | 1568 |
|
|
2022
Q3 | $8.15M | Sell |
151,509
-55,132
| -27% | -$2.83M | ﹤0.01% | 1024 |
|
|
2022
Q2 | $8.34M | Buy |
206,641
+1,184
| +0.6% | +$58.7K | ﹤0.01% | 1075 |
|
|
2022
Q1 | $13.6M | Sell |
205,457
-6,323
| -3% | -$433K | 0.01% | 967 |
|
|
2021
Q4 | $21.2M | Buy |
211,780
+43,399
| +26% | +$4.49M | 0.01% | 840 |
|
|
2021
Q3 | $21.1M | Sell |
168,381
-129,930
| -44% | -$15.4M | 0.01% | 881 |
|
|
2021
Q2 | $37M | Buy |
298,311
+2,410
| +0.8% | +$324K | 0.02% | 695 |
|
|
2021
Q1 | $45.2M | Sell |
295,901
-76,256
| -20% | -$11.5M | 0.02% | 622 |
|
|
2020
Q4 | $48M | Buy |
372,157
+81,401
| +28% | +$9.37M | 0.03% | 517 |
|
|
2020
Q3 | $32.5M | Sell |
290,756
-195,395
| -40% | -$17.9M | 0.02% | 571 |
|
|
2020
Q2 | $39.4M | Sell |
486,151
-34,984
| -7% | -$2.82M | 0.03% | 505 |
|
|
2020
Q1 | $36.3M | Buy |
521,135
+198,199
| +61% | +$15.2M | 0.03% | 457 |
|
|
2019
Q4 | $25.2M | Buy |
322,936
+223,005
| +223% | +$16.1M | 0.02% | 701 |
|
|
2019
Q3 | $6.38M | Buy |
99,931
+91,191
| +1,043% | +$8.03M | ﹤0.01% | 1259 |
|
|
2019
Q2 | $753K | Sell |
8,740
-15,714
| -64% | -$1.2M | ﹤0.01% | 3023 |
|
|
2019
Q1 | $1.87M | Buy |
24,454
+5,458
| +29% | +$303K | ﹤0.01% | 2557 |
|
|
2018
Q4 | $713K | Buy |
+18,996
| New | +$700K | ﹤0.01% | 3105 |
|
Other funds holding GH
DTC
Deutsche Bank's GH Position: Q2 2026 in Review
Deutsche Bank reduced its Guardant Health (GH) stake by 36% in Q2 2026, selling an estimated $10.1M and leaving 162,533 shares worth $24.4M. The position accounts for 0.01% of the portfolio, ranked #804.
Deutsche Bank first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $48M in Q4 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Deutsche Bank held 162,533 shares of Guardant Health worth $24.4M as of Q2 2026.
- Deutsche Bank sold 92,654 Guardant Health shares in Q2 2026, an estimated $10.1M.
- Guardant Health made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #804 holding.
- Deutsche Bank first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- Deutsche Bank's Guardant Health position peaked at $48M in Q4 2020.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.